Back to current studies

Do You Care for Someone with Mild to Moderate Alzheimer’s Disease?

NeuroTrials Research is conducting a new research study to evaluate the safety & efficacy of a new Alzheimer’s study drug taken with stable doses of Namenda (memantine HCL).

All study-related care, travel, and study drug will be provided at no cost, and participants & caregivers may be compensated for study-related time.

Qualified participants must be:

• be 50-85 years old
• have a diagnosis of Alzheimer’s Disease 
• be on a stable dose of Namenda for at least 3 months
• have a caregiver who is able and willing to comply with all required study procedures
• otherwise be in general good health